Research On Financial Performance Of Xiangxue Pharmacy Acquired Huqiao Pharmacy

With the continuous progress of the society and the continuous development of the economy,the competition in all walks of life is becoming increasingly fierce.In this competitive market environment,enterprises want to seek a better and more balanced development,and we must pay attention to the enhancement and strengthening of their own strength.Market development,technology promotion,and expand the scale of the enterprise overall is to increase their own strength,the effective method to increase the competitive advantage,and in recent years,the enterprise m&a has become a rapidly enhance strength and an important way of development and expansion.Mergers and acquisitions can expand the scale of capital,increase control,to reduce the risk of the market,make the enterprise not only in one’s own accumulation to slow development,it for the enterprise to break the existing pattern of expansion,the rapid development of business bigger and stronger provides a new way.High-speed development in the pharmaceutical industry and national policy guidance,the various government departments and organizations are actively promote the development of medicine industry,including the increasing strength of large enterprises to carry out their own strength for the purpose of restructuring or mergers and acquisitions work.However,the occurrence of mergers and acquisitions in different situations will have different effects on the performance of enterprises,and the m&a of pharmaceutical companies cannot focus on the number and scale of mergers and acquisitions.All sorts of mergers and acquisitions of pharmaceutical enterprises in our country will produce what kind of m&a performance,will affect the future development of the enterprise,how to further these is discussing our country medicine enterprise m&a must consider the problemAt first,this paper discusses the research background and research significance of m&a cases,and the instructive research results at home and abroad were reviewed,the review of the system is and puts forward the research methods and innovations of this article.Then the related concepts of m&a and m&a performance are explained and defined,and several evaluation methods of m&a performance are presented.Article then launched against xiangxue qiaocheng pharmaceutical pharmaceutical mergers and acquisitions Shanghai case of the analysis of the background and motivation,describes our country medicine industry development present situation and the characteristics of the mergers and acquisitions,and then the evaluation of financial performance for the merger and the evaluation conclusion.Through the study of the xiangxue pharmacy merger cases,it is concluded that the acquisition behavior of mergers and acquisitions financial,after the merger integration pressure slightly larger,but the acquisition conforms to the enterprise long-term development strategy.The merger and acquisition helps xiangxue to expand into the field of traditional Chinese medicine,improve the processing technology of traditional Chinese medicine,expand the industrial chain of traditional Chinese medicine,and lay the foundation for the further expansion of enterprises to become the industry leader.In this paper,the m&a of pharmaceutical enterprises is to achieve the expected m&a effect.It is necessary to make clear the purpose of m&a,avoid the blind acquisition,choose the payment method rationally,and pay attention to the integration after the merger.